Numinus Wellness Secures $6 Million in Public Offering to Fuel Psychedelic-Assisted Therapy Initiatives
LOS ANGELES- Numinus Wellness, a Vancouver-based healthcare company specializing in the innovative field of psychedelic-assisted therapies, has announced the successful completion of a significant...
FSD Pharma Announces Market Offering Agreement to Fund Research and Development
NEW YORK- FSD Pharma a biopharmaceutical company focused on developing a diverse portfolio of innovative assets and biotechnological solutions, has unveiled a strategic market...
Clearmind Medicine Inc. Advances Psychedelic Therapeutics with New Patent Applications
NEW YORK– Clearmind Medicine Inc. a biotech firm dedicated to the discovery and development of novel psychedelic-derived therapeutics, has taken significant steps to enhance...
MindBio Therapeutics Announces Completion of Groundbreaking Phase 2a LSD Microdose Trial
LOS ANGELES- In a significant advancement for psychiatric medicine, MindBio Therapeutics Corp., a pioneering biopharmaceutical company, has announced the successful completion of its Phase...
Silo Pharma Advances in Ketamine-Based Treatment for Chronic Pain
LOS ANGELES— In a significant stride toward innovative treatment for chronic pain conditions, Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company in its developmental...
PharmaDrug Inc. Completes Private Placement to Bolster Corporate Initiatives
LOS ANGELES- a specialty pharmaceutical company, announce the successful completion of its previously disclosed non-brokered private placement, raising total gross proceeds of $326,000.
In this...
